Impact of COVID-19 on clinical trials protocol amendments
Introduction: The COVID-19 pandemic situation had a great impact on all spheres of people’s lives. It also affected clinical trials as Sponsors, sites and investigators faced a number of problems, such as systematic IMP taking, adherence to protocol visits, efficacy evaluations, laboratory procedure...
Main Authors: | Anastasia A. Eleskina, Olga V. Filippova, Nathalia V. Pyatigorskaya |
---|---|
Format: | Article |
Language: | English |
Published: |
Belgorod National Research University
2023-04-01
|
Series: | Research Results in Pharmacology |
Subjects: | |
Online Access: | https://rrpharmacology.ru/index.php/journal/article/view/338/352 |
Similar Items
-
Common Clinical Trial Amendments, why they are submitted and how they can be avoided: a mixed methods study on NHS UK Sponsored Research (Amendments Assemble)
by: Shivam Joshi
Published: (2023-01-01) -
Risks of clinical trial protocol amendments according to duration of the trial
by: A. A. Eleskina, et al.
Published: (2023-07-01) -
Validation of the A&D UA‐651 Plus/UA‐651SL Plus automated sphygmomanometer according to the ISO 81060–2, 2018 and ISO 81060–2 Amendment 1, 2020, which resulted in the currently pending Amendment to Amendment 1
by: Bruce S. Alpert
Published: (2022-04-01) -
COVID U : BUSINESS LESSONS FROM A PANDEMIC /
by: Prag, Jay, author., et al.
Published: ([202) -
Human Behaviour in Pandemics : Social and Psychological Determinants in a Global Health Crisis /
by: Kossowska, Malgorzata, author 650480, et al.
Published: (2022)